Articles published in Journal of Cellular and Molecular Biology Research have been cited by esteemed scholars and scientists all around the world. Journal of Cellular and Molecular Biology Research has got h-index 1, which means every article in Journal of Cellular and Molecular Biology Research has got 1 average citations.
Following are the list of articles that have cited the articles published in Journal of Cellular and Molecular Biology Research.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
0 | 21 | 43 | 0 | 0 |
Year wise citations received |
4 | 7 | 1 | 1 | 1 |
| Journal total citations count | 13 |
| Journal Impact Factor | 0.52 |
| Journal 5 years Impact Factor | 0.25 |
| Journal CiteScore | 0.23 |
| Journal h-index | 1 |
| Journal Impact Factor 2020 formula |
| IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year |
| Journal 5-year Impact Factor 2020 formula |
| Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)} |
| Journal CiteScore |
| CiteScorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3 |
Tumor-Associated Glycans as Targets for Immunotherapy: The Wistar Institute Experience/Legacy |
|
Epithelial CCR2 promotes breast cancer progression directly and indirectly thru crosstalk with microenvironment populations |
|
Efficient and reproducible synthesis of an Fmoc-protected Tn antigen |
|
Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents |
|
A TLR4–TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells |
|
Activation of B-1 cells promotes tumor cell killing in the peritoneal cavity |
|
Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects |
|
The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective |
|
